fda compounding semaglutide enforcement 2025 news New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our 4-3-2026 💔❤️‍🩹👹, xoxo reta rat,

Read on to learn more about the different kinds of drug rashes, how theyre treated, and when you should seek medical care

The product is intended for laboratory and professional research use only

Weight-Loss Pills Are Here: What Novo Nordisks Daily GLP-1 Tablet Really Means for Patients The recent approval of a daily GLP-1 weight-loss pill by Novo Nordisk has generated widespread attention

To characterize the inspection record, I compared start date for the marketing of the product (NDC) with the most recent inspection date found in data from Redica Systems, a company that compiles inspection and CGMP compliance data from FDA and other major regulatory bodies around the world